136 related articles for article (PubMed ID: 396697)
1. Prostaglandins in circulatory disorders.
McGiff JC
Triangle; 1979; 18(4):101-7. PubMed ID: 396697
[No Abstract] [Full Text] [Related]
2. [Platelet function inhibitors in peripheral arteriopathies].
Strano A; Davì G; Cannizzaro S; Giubilato A
Recenti Prog Med; 1986 Apr; 77(4):205-9. PubMed ID: 2872704
[No Abstract] [Full Text] [Related]
3. Platelets and prostaglandins in sudden death: therapeutic implications.
Gelman JS; Mehta J
Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
[No Abstract] [Full Text] [Related]
4. [Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects].
Verdecchia P
Clin Ter; 1982 Apr; 101(2):179-94. PubMed ID: 7047054
[No Abstract] [Full Text] [Related]
5. [The inhibition of thrombocyte aggregation in vitro and in vivo].
Breddin K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):460-9. PubMed ID: 4193162
[No Abstract] [Full Text] [Related]
6. Inhibitors of platelet function and atherogenesis.
Rossi EC
Artery; 1979 Mar; 5(3):273-84. PubMed ID: 526133
[TBL] [Abstract][Full Text] [Related]
7. Evidence for 20 mg aspirin (ASA) as being optimal.
Sinzinger H; Virgolini I; Eyb R; Fitscha P; Kaliman J
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():303-6. PubMed ID: 2526489
[No Abstract] [Full Text] [Related]
8. [Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
Rhyner K; Stenger M; Block LH
Dtsch Med Wochenschr; 1984 Aug; 109(31-32):1211-4. PubMed ID: 6430669
[No Abstract] [Full Text] [Related]
9. Effects of dietary fatty acids, prostaglandins and related compounds on the role of platelets in thrombosis.
Srivastava KC
Biochem Exp Biol; 1980; 16(3):317-38. PubMed ID: 6268128
[No Abstract] [Full Text] [Related]
10. Prostaglandins and vascular function.
Weksler BB
Circulation; 1984 Nov; 70(5 Pt 2):III63-71. PubMed ID: 6386223
[No Abstract] [Full Text] [Related]
11. [Prostaglandins, platelets and cardiovascular disease].
Cunha-Ribeiro LM; de Pina-Cabral JM
Rev Port Cardiol; 1988; 7(1):63-80. PubMed ID: 3152542
[No Abstract] [Full Text] [Related]
12. Thromboxane and prostacyclin: implications for function and disease of the vasculature.
McGiff JC
Adv Intern Med; 1980; 25():199-216. PubMed ID: 6987841
[No Abstract] [Full Text] [Related]
13. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet agents: rationale and results.
Kelton JG
Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
[No Abstract] [Full Text] [Related]
15. Role of prostaglandins in the activity of some cardiovascular drugs.
Masotti G
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():319-26. PubMed ID: 2988313
[No Abstract] [Full Text] [Related]
16. Biologic interaction of prostaglandin, thromboxane and prostacyclin: potential clinical applications.
Bell TG; Smith WL; Oxender WD
J Environ Pathol Toxicol Oncol; 1986; 6(3-4):191-201. PubMed ID: 3012063
[TBL] [Abstract][Full Text] [Related]
17. [Polyunsaturated fatty acids, atherosclerosis and thrombosis].
Lagarde M
Arch Mal Coeur Vaiss; 1985 Dec; 78 Spec No():57-61. PubMed ID: 3010892
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
Danese CA; Haimov M
Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
[No Abstract] [Full Text] [Related]
19. Platelets, prostaglandins and thrombotic disorders.
de Gaetano G
Clin Haematol; 1981 Jun; 10(2):297-326. PubMed ID: 6274552
[No Abstract] [Full Text] [Related]
20. Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination.
Escolar G; Bastida E; Ordinas A; Castillo R
Thromb Res; 1985 Nov; 40(3):419-24. PubMed ID: 4082117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
